Cite

HARVARD Citation

    Mahe, M. et al. (2018). An FGFR3/MYC positive feedback loop provides new opportunities for targeted therapies in bladder cancers. EMBO molecular medicine. 10 (4), p. n/a. [Online]. 
  
Back to record